The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Eosinophilia & Hypereosinophilia Diagnosis & Treatment Tips

Eosinophilia & Hypereosinophilia Diagnosis & Treatment Tips

June 21, 2018 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Eosinophilia

Eosinophilia
LindseyRN / shutterstock.com

CHICAGO—High eosinophil counts that can’t be explained should concern rheumatologists and spark attempts to identify what’s happening, an expert said at the ACR State-of-the-Art Clinical Symposium in April.

You Might Also Like
  • Eosinophilia: A Diagnostic Evaluation Guide for Rheumatologists
  • Research Offers Insight into Diagnosis, Treatment of Small-Vessel Vasculitis
  • Case Report: Skin-Deep Eosinophils
Explore This Issue
June 2018
Also By This Author
  • Drug Tapering: Studies Point to Success in Some Patients

“Eosinophil counts over 1,500 (per microliter) should provoke worry,” said Bruce Bochner, MD, professor of medicine in allergy and immunology at Northwestern University Feinberg School of Medicine in Chicago. He cautioned that a patient with neutropenia will give a false increase in eosinophil percentage and, to obtain the true number, the white blood cell count should be multiplied by the eosinophil percentage.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The tip was among many offered in his talk for dealing with eosinophilia (counts of 500–1,500 per microliter) and hypereosinophilia (1,500 or more), which can be a manifestation of a variety of disorders, from allergies to drug reactions to leukemia.

The workup of a patient with eosinophilia or hypereosinophilia must be detailed and thorough, Dr. Bochner explained. The cause can be either primary or secondary, and can be characterized by its molecular cause or the organ involved. The treatment depends on the root cause, and expanding therapy options, he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Whenever possible, go back and try to figure out when the eosinophilia or hypereosinophilia began,” he said. “There may be a new drug. There may be associated travel. There may be

something that is easily reversible that you’ll pinpoint.”

Hypereosinophila in a patient with gastrointestinal symptoms should prompt concern for eosinophilic gastritis, he said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Two types of eosinophilia due to helminths that “you don’t want to miss” are Strongyloides stercoralis and Ascaris lumbricoides. Even though they are typically contracted in tropical climates, patients can be infected in regions of the U.S., so travel outside the country isn’t required. Strongyloides can disseminate and be lethal, especially if the patient is misdiagnosed and treated with corticosteroids, Dr. Bochner said.

Drug reactions with eosinophilia and systemic symptoms (DRESS) are typically marked by a measles-like rash starting two to eight weeks after taking the culprit drug and can prove life threatening, although the mechanisms at play are not well understood, he said.

‘In many of these conditions, one of the deadliest complications is endomyocardial involvement.’ —Dr. Bochner

In hypereosinophilia with myeloproliferative features, a gain-of-function deletion mutation has been identified, and the kinase inhibitor imatinib has yielded curative responses. This disorder tends to respond poorly to corticosteroids, Dr. Bochner said.

The lymphocytic variant, which can transform to malignancy, is mainly treated with corticosteroids, eventually combined with interferon alpha or other agents.

Pages: 1 2 | Single Page

Filed Under: Vasculitis Tagged With: Eosinophilia, hypereosinophilia, neutropeniaIssue: June 2018

You Might Also Like:
  • Eosinophilia: A Diagnostic Evaluation Guide for Rheumatologists
  • Research Offers Insight into Diagnosis, Treatment of Small-Vessel Vasculitis
  • Case Report: Skin-Deep Eosinophils
  • Advocate for Prompt Vasculitis Diagnosis & Treatment

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.